Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Pediatr Blood Cancer. 2010 Nov 12;57(2):275–282. doi: 10.1002/pbc.22821

Table I.

Patient Characteristic (n=21)

N (%)
Male/Female 15/6
Median Age (Range) 7.5 (0.8 – 25.6) years
Stage at Diagnosis
  1 1 (5%)
  3 1 (5%)
  4 19 (90%)
Tumor Biology at Diagnosis
  MYCN amplified 5 (24%)
  MYCN non-amplified 14 (67%)
  Unknown/not done 2 (10%)
  Favorable histology 0 (0%)
  Unfavorable histology 14 (67%)
  Unknown/not done 7 (33%)
Prior Therapies
  Chemotherapy 21 (100%)
  XRT 16 (76%)
  HDT/SCR 13 (62%)
  MIBG Therapy 7 (33%)
History of Tumor Relapse
prior to Study Entry
21 (100%)